Mirum Pharmaceuticals' promising pipeline and strong financials make it an attractive buy in the competitive PBC space. Click ...

Furthermore, alkaline phosphatase (ALP) staining results indicated that Qx-D had a positive effect on osteogenic ...

The FDA has granted breakthrough therapy designation Trodelvy for adults with extensive-stage small cell lung cancer who ...

Individuals with primary biliary cholangitis and diabetes may experience worse outcomes, such as progression to end-stage liver disease.

Primary biliary cholangitis (PBC) can deliver a significant blow to patients' quality of life, especially if they are not ...

INVESTIGATORS who have examined the distribution of alkaline phosphatase after starch-gel electrophoresis of extracts of human small intestine have found the main enzyme activity concentrated in a ...

2025 financial calendar for ALK (ALKB:DC / OMX: ALK B / AKBLF): 22 January 2025: Silent period 19 February 2025: Annual report 2024 13 March 2025 at 4.00 p.m.: Annual General Meeting ALK ...

Vertex Announces US FDA Approval of ALYFTREK™, a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis ...

Ensartinib has received FDA approval for the first-line treatment of ALK-positive locally advanced or metastatic non–small ...

Ensacove is approved for ALK-positive NSCLC patients who haven't received prior ALK-inhibitors, offering a new first-line treatment option. The eXALT3 trial showed Ensacove significantly improved ...

In that case, the patient had significantly elevated liver blood test values within 40 days of starting fezolinetant, ...